| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | V3DMU7PVXF |
| InChI Key | BXNMTOQRYBFHNZ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H22N4O2 |
| Molecular Weight | 314.39 |
| AlogP | 2.47 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 86.19 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 23.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 2056 | - | - | - | |
|
Membrane receptor
Toll-like and Il-1 receptors
|
250-1500 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Oligodendroglioma | 2 | D009837 | ClinicalTrials |
| Astrocytoma | 2 | D001254 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Lymphoma, T-Cell, Cutaneous | 2 | D016410 | ClinicalTrials |
| Keratosis, Actinic | 2 | D055623 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Influenza, Human | 1 | D007251 | ClinicalTrials |
| Carcinoma, Basal Cell | 1 | D002280 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Hepatitis B, Chronic | 1 | D019694 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 144875-48-9 |
| ChEBI | 36706 |
| ChEMBL | CHEMBL383322 |
| DrugBank | DB06530 |
| EPA CompTox | DTXSID7040603 |
| FDA SRS | V3DMU7PVXF |
| Guide to Pharmacology | 5051 |
| PDB | RX8 |
| PubChem | 159603 |
| SureChEMBL | SCHEMBL34159 |
| ZINC | ZINC000028572103 |